067370 — Sun Bio Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapFalling Star

Annual income statement for Sun Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Interim Report	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,547	5,459	9,965	7,420	12,292
Cost of Revenue
Gross Profit	3,706	3,439	6,728	4,514	8,636
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	4,868	3,820	6,588	7,229	7,100
Operating Profit	1,679	1,639	3,377	191	5,192
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,462	1,202	1,133	937	5,550
Provision for Income Taxes
Net Income After Taxes	1,462	1,202	285	869	4,607
Net Income Before Extraordinary Items
Net Income	1,462	1,202	285	869	4,607
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	1,462	1,168	285	869	4,607
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	127	100	24.5	72.6	374
Dividends per Share